MAPT and Alzheimer disease: Regarding a role for senescence in non-neuronal cells in AD, Bussian and co-authors showed that selectively removing senescent astrocytes and microglia cells with senolytics improved AD-related symptoms in a genetic mouse model of AD expressing the p19S tau mutation [51].